Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Terns Pharmaceuticals, Inc. TERN

Set alert

Price alert · TERN

All alert types
52.95 USD 0.00 0.00%

At close · May 15

52.97 +0.02 +0.04%

After hours · May 15, 4:00 PM ET

Bid
52.96 × 2
Ask
52.97 × 2
52.95 Day range 52.97
7.87 52-week range 53.19
YTD
+31.06%
1 year
+1,797.85%
Open
52.97
Prev close
52.95
Mkt cap
6.12B
Vol
6.33M
Avg vol
4.84M
EPS
-1.03
P/E
-68.77
Div yield
0.00%
More statistics
Low
52.95
High
52.97
Beta
-0.38
Inst. own
109.69%
Dividend
0.00

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Mar 26, 2026Downgrade: TD Cowen · Buy → Hold
  • Mar 26, 2026Downgrade: Citizens · Market Outperform → Market Perform
  • Mar 30, 2026Earnings: -0.25; estimate -0.29; surprise 13.79%
  • Mar 30, 2026Downgrade: Barclays · Overweight → Equal-Weight
  • Mar 31, 2026Downgrade: Truist Securities · Buy → Hold
  • Apr 14, 2026Rating: JP Morgan · Overweight → Overweight
  • Apr 27, 2026Downgrade: Oppenheimer · Outperform → Perform
Signals (18)
NameDateAgo
MACD: Sell SignalApr 7, 20266 months ago
RSI: OverboughtMar 23, 20267 months ago
RSI: OverboughtMar 19, 20267 months ago
RSI: OverboughtMar 9, 20267 months ago
SMA: BullishFeb 17, 20268 months ago
SMA: BearishFeb 12, 20268 months ago
SMA: BullishFeb 6, 20268 months ago
MACD: Buy SignalFeb 6, 20268 months ago
MACD: Sell SignalFeb 5, 20269 months ago
SMA: BearishFeb 4, 20269 months ago
MACD: Buy SignalFeb 4, 20269 months ago
SMA: BullishFeb 2, 20269 months ago
SMA: BearishJan 23, 20269 months ago
MACD: Sell SignalDec 19, 202510 months ago
MACD: Buy SignalDec 8, 202510 months ago
RSI: OverboughtDec 5, 202511 months ago
RSI: OverboughtDec 3, 202511 months ago
MACD: Sell SignalDec 2, 202511 months ago

Financial health

Altman Z-Score

197.94 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -39.2×
FY 2018: -24.9×FY 2019: -6.7×FY 2020: -11.4×FY 2021: -3.6×FY 2022: -6.1×FY 2023: -5.1×FY 2024: -4.9×FY 2025: -39.2×
FY 2018 5y median -5.1× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 179×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 3.7×
FY 2018: 6.1×FY 2019: 110×FY 2020: 6.7×FY 2021: 1.1×FY 2022: 1.3×FY 2023: 1.8×FY 2024: 1.3×FY 2025: 3.7×
FY 2018 5y median 1.3× FY 2025
P/FCF -45.8×
FY 2018: -24.1×FY 2019: -6.9×FY 2020: -15.2×FY 2021: -4.2×FY 2022: -7.4×FY 2023: -6.9×FY 2024: -6.3×FY 2025: -45.8×
FY 2018 5y median -6.9× FY 2025
EV/EBITDA -34.1×
FY 2018: -19.5×FY 2019: -6.5×FY 2020: -10.9×FY 2021: -2.7×FY 2022: -3.8×FY 2023: -4.3×FY 2024: -3.2×FY 2025: -34.1×
FY 2018 5y median -3.8× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 131×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -2.2%
FY 2018: -4.2%FY 2019: -14.5%FY 2020: -6.6%FY 2021: -23.6%FY 2022: -13.5%FY 2023: -14.6%FY 2024: -15.9%FY 2025: -2.2%
FY 2018 5y median -14.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -4986.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -5015.8%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -9.6%
FY 2018: -24.5%FY 2019: -1635.8%FY 2020: -42.8%FY 2021: -31.3%FY 2022: -21.8%FY 2023: -35.3%FY 2024: -25.7%FY 2025: -9.6%
FY 2018 5y median -25.7% FY 2025
ROIC -10.9%
FY 2018: -21.2%FY 2019: -370.2%FY 2020: -45.0%FY 2021: -30.9%FY 2022: -22.2%FY 2023: -39.9%FY 2024: -29.2%FY 2025: -10.9%
FY 2018 5y median -29.2% FY 2025
ROA -9.4%
FY 2018: -19.9%FY 2019: -287.9%FY 2020: -31.8%FY 2021: -29.8%FY 2022: -21.0%FY 2023: -33.6%FY 2024: -24.4%FY 2025: -9.4%
FY 2018 5y median -24.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income -8.1%
FY 2018: 0.0%FY 2019: -280.4%FY 2020: 47.3%FY 2021: -34.7%FY 2022: -24.4%FY 2023: -65.3%FY 2024: 0.7%FY 2025: -8.1%
FY 2018 FY 2025
EPS (diluted) 8.0%
FY 2018: 0.0%FY 2019: -270.3%FY 2020: 41.2%FY 2021: -23.0%FY 2022: 15.7%FY 2023: 24.0%FY 2024: 11.8%FY 2025: 8.0%
FY 2018 FY 2025
Free Cash Flow -17.3%
FY 2018: 0.0%FY 2019: -266.5%FY 2020: 54.7%FY 2021: -38.7%FY 2022: -17.1%FY 2023: -36.6%FY 2024: -3.9%FY 2025: -17.3%
FY 2018 FY 2025

Financial Health

Current Ratio 62.4×
FY 2018: 37.3×FY 2019: 4.5×FY 2020: 4.0×FY 2021: 24.5×FY 2022: 33.7×FY 2023: 22.4×FY 2024: 23.1×FY 2025: 62.4×
FY 2018 5y median 24.5× FY 2025
Quick Ratio 62.4×
FY 2018: 37.3×FY 2019: 4.5×FY 2020: 4.0×FY 2021: 24.5×FY 2022: 33.7×FY 2023: 22.4×FY 2024: 23.1×FY 2025: 62.4×
FY 2018 5y median 24.5× FY 2025
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 5.5×
FY 2018: 4.5×FY 2019: 0.2×FY 2020: 1.7×FY 2021: 1.0×FY 2022: 2.4×FY 2023: 0.9×FY 2024: 1.8×FY 2025: 5.5×
FY 2018 5y median 1.8× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31